Literature DB >> 12208678

Adverse cardiac events in emergency department patients with chest pain six months after a negative inpatient evaluation for acute coronary syndrome.

Alex F Manini1, Michael A Gisondi, Theresa M van der Vlugt, Donald H Schreiber.   

Abstract

OBJECTIVE: To evaluate the impact of the diagnostic test setting-inpatient versus outpatient-on adverse cardiac events (ACEs) after six months in emergency department (ED) patients with chest pain who were admitted to the hospital and subsequently had a negative evaluation for acute coronary syndrome (ACS).
METHODS: The authors retrospectively studied a consecutive sample of ED patients with chest pain over a nine-month period. All patients were admitted to the hospital and underwent negative evaluations for ACS, defined as the absence of diagnostic changes on serial electrocardiograms or cardiac markers (creatine kinase-MB and troponin T), and a negative diagnostic cardiac study. Subjects were classified according to cardiac diagnostic study setting-either inpatient or outpatient. Diagnostic testing included exercise treadmill, angiography, stress echocardiography, or stress thallium scans. Acute cardiac events at six months were defined as cardiac death, myocardial infarction, unstable angina, cardiac arrest, or emergent revascularization.
RESULTS: The six-month rate of ACEs among 157 subjects was 14%, with 2% cardiac mortality. The outpatient group had higher ACE risk when compared with the inpatient group using multivariate logistic regression, both for the entire cohort (OR 3.5, p < 0.03) and for a subgroup excluding patients with prior coronary artery disease (OR 6.7, p < 0.05). The outpatient group included 19 of 52 (37%) noncompliant subjects who did not receive a diagnostic study.
CONCLUSIONS: Long-term cardiac morbidity of patients after a negative ACS evaluation may be higher than previously thought. Risk of ACE is significantly higher in subjects scheduled for outpatient diagnostic tests. Inpatient diagnostic testing is justified for subjects at risk for poor compliance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12208678     DOI: 10.1111/j.1553-2712.2002.tb02190.x

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  7 in total

1.  Compliance with stress testing in patients discharged from the emergency department following a diagnosis of low-risk chest pain.

Authors:  Kent Robinson; Shreyas Prabhala
Journal:  Heart Asia       Date:  2014-08-08

Review 2.  Testing of low-risk patients presenting to the emergency department with chest pain: a scientific statement from the American Heart Association.

Authors:  Ezra A Amsterdam; J Douglas Kirk; David A Bluemke; Deborah Diercks; Michael E Farkouh; J Lee Garvey; Michael C Kontos; James McCord; Todd D Miller; Anthony Morise; L Kristin Newby; Frederick L Ruberg; Kristine Anne Scordo; Paul D Thompson
Journal:  Circulation       Date:  2010-07-26       Impact factor: 29.690

3.  Coronary computerized tomography angiography for rapid discharge of low-risk patients with cocaine-associated chest pain.

Authors:  Kristy Walsh; Anna Marie Chang; Jeanmarie Perrone; Christine McCusker; Frances Shofer; Mark Collin; Harold Litt; Judd Hollander
Journal:  J Med Toxicol       Date:  2009-09

4.  The role of myeloperoxidase (MPO) for prognostic evaluation in sensitive cardiac troponin I negative chest pain patients in the emergency department.

Authors:  Julia Searle; Jessie Shih; Reinhold Muller; Jörn O Vollert; Christian Müller; Oliver Danne; Saul Datwyler; Martin Möckel
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-09

5.  Pretest probability assessment derived from attribute matching.

Authors:  Jeffrey A Kline; Charles L Johnson; Charles V Pollack; Deborah B Diercks; Judd E Hollander; Craig D Newgard; J Lee Garvey
Journal:  BMC Med Inform Decis Mak       Date:  2005-08-11       Impact factor: 2.796

6.  Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study.

Authors:  Martin Möckel; Julia Searle; Christian Hamm; Anna Slagman; Stefan Blankenberg; Kurt Huber; Hugo Katus; Christoph Liebetrau; Christian Müller; Reinhold Muller; Philipp Peitsmeyer; Johannes von Recum; Milos Tajsic; Jörn O Vollert; Evangelos Giannitsis
Journal:  Eur Heart J       Date:  2014-04-30       Impact factor: 29.983

7.  Automated detection of healthy and diseased aortae from images obtained by contrast-enhanced CT scan.

Authors:  Michael Gayhart; Hiroshi Arisawa
Journal:  Comput Math Methods Med       Date:  2013-03-31       Impact factor: 2.238

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.